1. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation
- Author
-
Jean-Paul Brion, Hervé Pelloux, Marie-Pierre Brenier-Pinchart, O. Chavanon, Hélène Fricker-Hidalgo, M. Durand, Laboratoire Adaptation et pathogénie des micro-organismes [Grenoble] (LAPM), and Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)
- Subjects
Lung Diseases, Parasitic ,medicine.medical_treatment ,Antibodies, Protozoan ,Serology ,law.invention ,0302 clinical medicine ,law ,MESH: Immunocompromised Host ,MESH: Sulfadiazine ,Polymerase chain reaction ,Heart transplantation ,0303 health sciences ,biology ,MESH: Heart Transplantation ,3. Good health ,Pyrimethamine ,Infectious Diseases ,MESH: Toxoplasmosis ,Female ,Antibody ,Toxoplasmosis ,Adult ,medicine.medical_specialty ,MESH: Pyrimethamine ,030231 tropical medicine ,Antiprotozoal Agents ,Sulfadiazine ,Disseminated toxoplasmosis ,Immunocompromised Host ,03 medical and health sciences ,Internal medicine ,Sulfadoxine ,Pulmonary toxoplasmosis ,medicine ,Humans ,MESH: Antibodies, Protozoan ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,MESH: Antiprotozoal Agents ,MESH: Lung Diseases, Parasitic ,Transplantation ,MESH: Humans ,030306 microbiology ,business.industry ,MESH: Adult ,medicine.disease ,Immunology ,biology.protein ,Heart Transplantation ,business ,MESH: Female ,MESH: Sulfadoxine - Abstract
We report a case of pulmonary toxoplasmosis after heart transplant despite the prophylactic anti-toxoplasmic treatment that was given but was not sufficient to prevent toxoplasmosis. However, the patient survived thanks to early diagnosis confirmed by polymerase chain reaction on blood and by serological techniques, and early treatment.
- Published
- 2005
- Full Text
- View/download PDF